InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in InMed Pharmaceuticals Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −2 vs. Q1 2021
- Shares held
- 944.9K
- +477.9K (+102.3%) vs. Q1 2021
- Total value
- $2.99M
- +$1.44M (+92.6%) vs. Q1 2021
- New holders
- 3
- 4 more added
- Sold out
- 5
- 4 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $4.18M |
| Q1 2026 | 9 | $206.0K |
| Q4 2025 | 7 | $240.7K |
| Q3 2025 | 9 | $665.2K |
| Q2 2025 | 7 | $28.5K |
| Q1 2025 | 5 | $13.3K |
| Q4 2024 | 5 | $226.7K |
| Q3 2024 | 15 | $266.0K |
| Q2 2024 | 14 | $116.6K |
| Q1 2024 | 18 | $249.2K |
| Q4 2023 | 17 | $334.4K |
| Q3 2023 | 10 | $18.6K |
| Q2 2023 | 10 | $14.5K |
| Q1 2023 | 15 | $109.4K |
| Q4 2022 | 14 | $234.4K |
| Q3 2022 | 15 | $876.9K |
| Q2 2022 | 18 | $514.5K |
| Q1 2022 | 19 | $341.9K |
| Q4 2021 | 18 | $536.4K |
| Q3 2021 | 19 | $979.9K |
| Q2 2021 | 20 | $2.99M |
| Q1 2021 | 22 | $1.55M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding InMed Pharmaceuticals Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 890,000 | $2.83M | 0.08% | +655,000+278.7% | Added |
| Citadel Advisors LLC | 15,310 | $49.0K | 0.00% | −1,901−11.0% | Reduced |
| Penserra Capital Management LLC | 19,912 | $49.0K | 0.00% | +19,912 | New |
| Creative Planning | 10,841 | $34.0K | 0.00% | −149−1.4% | Reduced |
| UBS Group AG | 2,210 | $7.00K | 0.00% | +1,417+178.7% | Added |
| The PNC Financial Services Group, Inc. | 1,820 | $6.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,005 | $4.00K | 0.00% | +69+7.4% | Added |
| Morgan Stanley | 813 | $2.00K | 0.00% | −11,768−93.5% | Reduced |
| Reilly Financial Advisors, LLC | 700 | $2.00K | 0.00% | 00.0% | Unchanged |
| AllSquare Wealth Management LLC | 545 | $2.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 511 | $1.63K | 0.00% | +221+76.2% | Added |
| Royal Bank of Canada | 250 | $1.00K | 0.00% | −336−57.3% | Reduced |
| FourThought Financial, LLC | 424 | $1.00K | 0.00% | 00.0% | Unchanged |
| HC Financial Advisors Inc | 24 | $0 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 125 | $0 | 0.00% | 00.0% | Unchanged |
| Banque Cantonale Vaudoise | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Navigation Wealth Management, Inc. | 65 | $0 | 0.00% | 00.0% | Unchanged |
| Better Money Decisions, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 50 | $0 | 0.00% | +50 | New |
| Advisory Services Network, LLC | 151 | $0 | 0.00% | +151 | New |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −161,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −16,120−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −7,472−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −168−100.0% | Sold out |
| Certified Advisory Corp | 0 | $0 | 0.00% | −30−100.0% | Sold out |